Acute Toxicity and Genotoxic Evaluation of Metlin® and Metlos® (Organic Agave Fructans)


The aim of the study was to contribute to the information on agave soluble fibers since research has been focused on chicory fiber but not in agave products; thus we assess the acute toxicity and genotoxicity of two organic and high purity dietary soluble fibers from agave, Metlin? and Metlos?. We performed an acute toxicity assay in Hsd:ICR mice and Hsd:Wistar rats and an in vivo genotoxic test. Results showed that there are no deaths at any doses or genotoxicity, so it can be concluded that these products are non-toxic, at the administrated doses and none showed a cytotoxic, clastogenic or aneuploidic effect.

Share and Cite:

M. Gracia, M. Tinoco, H. Rivera, B. Sanchez, P. Tapia, L. Altamirano, R. Romero and O. García, "Acute Toxicity and Genotoxic Evaluation of Metlin® and Metlos® (Organic Agave Fructans)," Food and Nutrition Sciences, Vol. 4 No. 7A, 2013, pp. 106-112. doi: 10.4236/fns.2013.47A013.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Y. Palencia, “Qué son los Alimentos Funcionales.”
[2] C. Thomson and A. Bloch, “Position of the American Dietetic Association: Functional Foods,” Journal of the American Diet Association, Vol. 99, No. 10, 1999, pp. 1278-1285. doi:10.1016/S0002-8223(99)00314-4
[3] G. Olveira Fuster and I. González-Molero, “Probióticos Prebióticos en la Práctica Clínica,” Nutrición Hospitalaria, Vol. 22, No. 2, 2007, pp. 26-34.
[4] G. Olagnero, A. Abad and S. Bendersky, “Alimentos Funcionales: Fibra, Prebióticos, Probióticos y Simbióticos,” 2007.
[5] D. Marquina and A. Santos, “Probióticos, Prebióticos y Salud,” Actualidad SEM, Vol. 32, 2001, pp. 24-27.
[6] J. Schrezenmeir and J. De Vrese, “Probiotics, Prebiotics and Synbiotics—Approaching a Definition,” American Journal of Clinical Nutrition, Vol. 73, No. 2, 2001, pp. 361-364.
[7] WHO, “Diet, Nutrition and the Prevention of Chronic Diseases,” Report of a Joint FAO/WHO Expert Consultation, World Health Organ, Technical Report Series, 2003, pp. 1-149.
[8] R. Meier and M. A. Gassull, “Consensus Recommendations on the Effects and Benefits of Fibre in Clinical Practice,” Clinical Nutrition Supplements, Vol. 1, No. 2, 2004, pp. 73-80. doi:10.1016/j.clnu.2004.09.011
[9] EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), “Scientific Opinion on Dietary Reference Values for Carbohydrates and Dietary Fibre,” EFSA Journal, Vol. 8, No. 3, 2010, p. 1462.
[10] Institute of Medicine, “Dietary Reference Intakes for Energy, Carbohydrates, Fibers, Fats, Fatty Acids, Cholesterol, Protein and Aminoacids,” pp. 7-8.
[11] Secretaría de Economía, “NOM-051-SCFI-/SSA1-2010: Especificaciones Generales de Etiquetadopara Alimentos y Bebidas No Alcohólicas Preenvasadas,” pp. 17-27.
[12] Australian National Health and Medical Research Council (NHMRC) and New Zealand Ministry of Health Nutrient, “Reference Values for Australia and New Zealand Including Recommended Dietary Intakes,” p. 47.
[13] Grupo Mercado Común, “Reglamen to Técnico Mercosursobre el Rotulado Nutricional de Alimentos Envasados,” p. 12.
[14] D. H. Lewis, “Nomenclature and Diagrammatic Representation of Oligomeric Fructans—A Paper for Discussion,” New Phytologist, Vol. 124, No. 4, 1993, pp. 583594. doi:10.1111/j.1469-8137.1993.tb03848.x
[15] J. Cummings and W. Frohlich, “Dietary Fiber Intakes in Europe: An Overview,” Commission of the European Community, DGXII-COST 92, 1993.
[16] M. Roberfroid, G. Gibson and N. Delzenne, “Biochemistry of Oligofructose, a Non-Digestible Dietary Fiber: An Approach to Calculate Its Caloric Value,” Nutrition Reviews, Vol. 51, 1993, pp. 137-146. doi:10.1111/j.1753-4887.1993.tb03090.x
[17] G. Gibson, E. Beatty and X. Wang, “Selective Stimulation of Bifidobacteria in the Human Colon by Oligofructose and Inulin,” Gastroenterology, Vol. 108, No. 4, 1995, pp. 975-982. doi:10.1016/0016-5085(95)90192-2
[18] K. Yamashita, K. Kawai and K. Itakura, “Effect of Fructooligosaccharides on Blood Glucose and Serum Lipids in Diabetic Subjects,” Nutrition Research, Vol. 4, No. 6, 1984, pp. 961-966. doi:10.1016/S0271-5317(84)80075-5
[19] J. Luo, S. Rizkala and C. Alamowitch, “Chronic Consumption of Short-Chain Fructooligosaccharides by Healthy Subjects Decreased Basal Glucose Production but Had No Effect on Insulin-Stimulated Glucose Metabolism,” American Journal of Clinical Nutrition, Vol. 63, 1996, pp. 939-945.
[20] E. Canzi, F. Brighenti and M. Casighari, “Prolonged Consumption of Inulin in Ready-to-Eat Breakfast Cereals: Effects on Intestinal Ecosystem, Bowel Habits and Lipid Metabolism,” Cost 92, Workshop on Dietary Fiber and Fermentation in the Colon, Helsinki, 1995, pp. 15-17.
[21] C. Williams, “Effects of Inulin on Lipid Parameters in Humans,” Journal of Nutrition, Vol. 129, No. 7, 1999, pp. 1471S-1473S.
[22] M. Davidson, K. Maki and C. Synecki, “Effects of Dietary Inulin on Serum Lipids in Men and Women with Hypercholesterolemia,” Nutrition Research, Vol. 18, No. 3, 1998, pp. 503-517. doi:10.1016/S0271-5317(98)00038-4
[23] J. Sellin, S. Meredith and S. Kelly, “Prospective Evaluation of Metabolic Bone Disease after Jejunoileal ByPass,” Gastroenterology, Vol. 87, 1984, pp. 123-129.
[24] C. Colette, M. Gouttebel and L. Monnier, “Calcium Absorption Following Small Bowel Resection in Man. Evidencer for an Adaptive Response,” European Journal of Clinical Investigation, Vol. 16, No. 4, 1986, pp. 271-276. doi:10.1111/j.1365-2362.1986.tb01341.x
[25] A. Ohta, M. Ohtsuki and S. Baba, “Effects of Fructooligosaccharides on the Absorption of Iron, Calcium and Magnesium in Iron-Deficient Anemic Rats,” Journal of Nutritional Science and Vitaminology, Vol. 41, No. 3, 1995, pp. 281-291. doi:10.3177/jnsv.41.281
[26] O. Chonan and R. Takahashi, “β1->4 Linked Galactooligosaccharides Stimulate Calcium and Magnesium Absorption from the Large Intestine,” Annual Report of Yakult Central Institute for Microbiological Research, Vol. 19, 1999, pp. 53-59.
[27] O. Chonan, R. Takahashi and M. Watanuki, “Role of Activity of Gastrointestinal Microflora in Absorption of Calcium and Magnesium in Rats Fed β1->4 Linked Galactooligosaccharides,” Bioscience, Biotechnology, and Biochemistry, Vol. 65, No. 8, 2001, pp. 1872-1875. doi:10.1271/bbb.65.1872
[28] K. Scholz-Ahrens, G. Schaafsma and E. Van Den Heuvel, “Effects of Prebiotics on Mineral Metabolism,” American Journal of Clinical Nutrition, Vol. 73, 2001, pp. 459S464S.
[29] A. Lorenzo Monterrubio, “Las Haciendas Pulqueras de México,” Universidad NacionalAutónoma de México, México, 2007.
[30] C. Gibson, “Los Aztecas Bajo el Dominio Espaol 15191810,” 14th Edición, Siglo XXI, México, 2000.
[31] Organization for Economic Co-operation and Development, “Guidelines for the Testing of Chemicals, Doc 475: Mammalian Bone Marrow Chromosome Aberration Test,” 1997.
[32] EPA, “Health Effects Test Guidelines OPPTS 870.5385 Mammalian Bone Marrow Chromosome Aberration Test,” 1998.
[33] M. Hayashi, T. Morita and Y. Kodoma, “The Micronucleous Assay with Mouse Peripheral Blood Reticulocites Using Acridine Orange-Coated Slides,” Mutation Research, Vol. 245, No. 4, 1990, pp. 245-249. doi:10.1016/0165-7992(90)90153-B
[34] M. C. García Rodríguez, V. López-Santiago and M. Altamirano-Lozano, “Effect of Chlorophyllin on Chromium Trioxide Induced Micronuclei in Polychromatic Erythrocytes of Mice Peripheral Blood,” Mutation Research, Vol. 496, No. 1-2, 2001, pp. 145-151. doi:10.1016/S1383-5718(01)00225-X
[35] J. Gill, “Generalized Linear Models: A Unified Approach,” Sage University Papers Series on Quantitative Applications in the Social Sciences, 07-134, 2000.
[36] M. J. Marques de Cantú, “Probabilidad y Estadística: Para Ciencias Químico-Biológicas,” McGraw-Hill, México, 1990.
[37] M. L. Samuels and J. A. Witmer, “Statistics for the Life Sciences,” 2nd Edition, Prentice-Hall, 1999.
[38] F. R. Johannsen, “Toxicological Profile of Carboxymethyl Inulin,” Food and Chemical Toxicology, Vol. 41, No. 1, 2003, pp. 49-59. doi:10.1016/S0278-6915(02)00213-2
[39] I. G. Carabin and W. G. Flamm, “Evaluation of Safety of Inulin and Oligofructose as Dietary Fiber,” Regulatory Toxicology and Pharmacology, Vol. 30, No. 3, 1999, pp. 268-282. doi:10.1006/rtph.1999.1349

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.